Download presentation
Presentation is loading. Please wait.
Published byAnna Morgan Modified over 8 years ago
1
Table 1. Criteria for differentiating acute and chronic hepatitis C Suggested citation: European Centre for Disease Prevention and Control. Annual epidemiological report 2015. Hepatitis C. Stockholm: ECDC; 2016. © European Centre for Disease Prevention and Control, 2016. Reproduction is authorised, provided the source is acknowledged StageDefinition Acute Recent HCV seroconversion (prior negative test for hepatitis C in last 12 months) or Detection of hepatitis C virus nucleic acid (HCV RNA) or hepatitis C virus core antigen (HCV-core) in serum/plasma and no detection of hepatitis C virus antibody (negative result) Chronic Detection of hepatitis C virus nucleic acid (HCV RNA) or hepatitis C core antigen (HCV-core) in serum/plasma in two samples taken at least 12 months apart* UnknownAny newly diagnosed case which cannot be classified in accordance with the above definition of acute or chronic infection
2
Table 2. Number and rate of reported hepatitis C cases per 100 000 population, EU/EEA, 2010–2014 † † Data presented by date of diagnosis. * Includes the cases reported by countries as acute, chronic or unknown using the differentiation criteria Source: Country reports Suggested citation: European Centre for Disease Prevention and Control. Annual epidemiological report 2015. Hepatitis C. Stockholm: ECDC; 2016. © European Centre for Disease Prevention and Control, 2016. Reproduction is authorised, provided the source is acknowledged 20102011201220132014 Country All Acute*Chronic*Unknown* CasesRateCasesRateCasesRateCasesRateCasesRateCasesRateCasesRateCasesRate Austria88010.5112213.4107512.899311.7195423931.191310.794811.1 Belgium 1151 Bulgaria580.8600.8921.3951.3901.2 Croatia 17142024.71443.4 Cyprus263.2576.8485.6364.2303.5 303.5 Czech Republic7096.88127.77967.69298.88087.7 8087.7 Denmark3185.72955.32634.72654.71813.260.11733.120 Estonia27620.721015.824518.527320.731523.9201.529522.4 Finland113821.3113521.1116521.6117221.6122422.5 122422.5 France Germany52816.550756.249786.151686.357377.1 57377.1 Greece110.1180.2430.4220.2180.22<0.1160.1 Hungary110.1430.4380.4460.5430.4430.4 Iceland5918.67222.651167222.43811.7 3811.7 Ireland124027.3125427.4102622.477816.969415.1210.5681.560513.1 Italy2360.42340.42210.42050.3450.1 450.1 Latvia115654.5132463.8135266.1132765.6149174.5572.8143471.6 Lithuania411.3431.4401.3592341.2341.2 Luxembourg7314.57414.55310.16812.76812.4 6812.4 Malta143.4184.3245.7143.3143.310.2133.1 Netherlands310.2680.4570.3650.4520.3520.3 Norway178336.7167534151330.3131826.1121323.7 121323.7 Poland21795.722415.92265626416.935519.3 Portugal390.4450.4420.4210.2630.670.1 560.5 Romania760.4800.41260.61270.61040.5840.4200.1 Slovakia2374.43045.62304.33145.83817350.63466.4 Slovenia874.3954.61025894.3643.130.1613 Spain Sweden193920.8215322.9199021200521178618.5 178618.5 United Kingdom995115.91213819.31347421.21375721.51402821.8 129121273719.8 Total EU/EEA278497.3306458314808.1320618.3353218.84580.546983.7263809.5
3
Figure 1. Rate of acute and chronic hepatitis C cases per 100 000 population, EU/EEA, 2006–2014 Source: Country reports from Austria, Belgium, Bulgaria, Croatia, Cyprus, the Czech Republic, Denmark, Estonia, Finland, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, the Netherlands, Norway, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden, and the United Kingdom. Suggested citation: European Centre for Disease Prevention and Control. Annual epidemiological report 2015. Hepatitis C. Stockholm: ECDC; 2016. © European Centre for Disease Prevention and Control, 2016. Reproduction is authorised, provided the source is acknowledged
4
Figure 2. Rate of reported acute hepatitis C cases per 100 000 population, EU/EEA, 2014 Source: Country reports from Austria, Bulgaria, Croatia, Cyprus, the Czech Republic, Denmark, Estonia, Finland, Germany, Greece, Iceland, Ireland, Italy, Latvia, Luxembourg, Malta, Norway, Poland, Romania, Slovakia, Slovenia, Sweden, and the United Kingdom. Suggested citation: European Centre for Disease Prevention and Control. Annual epidemiological report 2015. Hepatitis C. Stockholm: ECDC; 2016. © European Centre for Disease Prevention and Control, 2016. Reproduction is authorised, provided the source is acknowledged
5
Figure 3. Rate of reported hepatitis C cases per 100 000 population, by age and gender, EU/EEA, 2014 Source: Country reports from Austria, Belgium, Bulgaria, Croatia, Cyprus, the Czech Republic, Denmark, Estonia, Finland, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, the Netherlands, Norway, Poland, Portugal, Romania, Slovakia, Slovenia, Sweden, and the United Kingdom. Suggested citation: European Centre for Disease Prevention and Control. Annual epidemiological report 2015. Hepatitis C. Stockholm: ECDC; 2016. © European Centre for Disease Prevention and Control, 2016. Reproduction is authorised, provided the source is acknowledged
6
Figure 4. Transmission category of hepatitis C cases by acute and chronic disease status, EU/EEA, 2014 Source: Country reports from Austria, Denmark, Estonia, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, the Netherlands, Portugal, Romania, Slovakia, Slovenia, and the United Kingdom. Suggested citation: European Centre for Disease Prevention and Control. Annual epidemiological report 2015. Hepatitis C. Stockholm: ECDC; 2016. © European Centre for Disease Prevention and Control, 2016. Reproduction is authorised, provided the source is acknowledged
7
Table. Hepatitis C, surveillance systems overview, 2014 Surveillance characteristics: compulsory (Cp), comprehensive (co), voluntary (V), other (O), active (A), passive (P), case-based (C), aggregated (A) Data reported by: laboratories (L), physicians (P), hospitals (H), other (O) Suggested citation: European Centre for Disease Prevention and Control. Annual epidemiological report 2016. Hepatitis C. Stockholm: ECDC; 2016. © European Centre for Disease Prevention and Control, 2016. Reproduction is authorised, provided the source is acknowledged Surveillance Data reported byCase definition used characteristics CountryData source LPHO AustriaAT-EpidemiegesetzCoC YYYYEU-2008 BelgiumBE-LABNETSeCYN..Other BulgariaBG-NATIONAL_SURVEILLANCECoH YYYYEU-2008 CroatiaHR-CNIPHCoAYYYYEU-2012 CyprusCY-NOTIFIED_DISEASESCoC NYNNEU-2008 Czech Republic CZ-EPIDATCoCNYYNEU-2008 DenmarkDK-MISCoC NYNNOther EstoniaEE-NAKISCoCYYYNEU-2012 FinlandFI-NIDRCoC YYNNEU-2012 GermanyDE-SURVNET@RKI-7.1/6CoCYYYYOther GreeceEL-NOTIFIABLE_DISEASESCoC YYYNEU-2008 HungaryHU-EFRIRCoCYYYNEU-2012 IcelandIS-SUBJECT_TO_REGISTRATIONCoC YYYNEU-2012 IrelandIE-CIDRCoCYYYNEU-2012 ItalyIT-NRSCoC NYYNOther ItalyIT-SEIEVASeCNYYNEU-2012 LatviaLV-BSNCoC YYYYEU-2012 LithuaniaLT-COMMUNICABLE_DISEASESCoCNYNNEU-2012 LuxembourgLU-SYSTEM1CoC NYNNOther MaltaMT-DISEASE_SURVEILLANCECoCYYYYEU-2012 NetherlandsNL-OSIRISCoC YYNNEU-2008 NorwayNO-MSIS_ACoCYYYNEU-2012 PolandPL-NATIONAL_SURVEILLANCECoH NYYNEU-2008 PortugalPT-HEPATITISCCoCNYNNOther RomaniaRO-RNSSyCoC YNYNOther SlovakiaSK-EPISCoCYYYNEU-2012 SloveniaSI-SURVIVALCoC YYYNEU-2012 SwedenSE-SMINETCoCYYYNEU-2012 United Kingdom UK-HEPATITISCCoC YNYNEU-2012
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.